Skip to content
Stop using now Drug recall · FDA · Published August 10, 2016

Allergy Labs Recalls Ephedrine Sulfate Injection Due to Sterility Risks

Allergy Laboratories, Inc. recalls Ephedrine Sulfate Injection vials due to lack of sterility assurance. Check lot numbers and expiration dates for affected units.

🇺🇸 FDA recall #D-1498-2016DrugAllergy Laboratories ›
Take action

Contact the company

Recalling firmAllergy Laboratories, Inc.1005 SW 2nd St · Oklahoma City, OK 73109-1006
✎ GovInfoNow plain-language explainer

What happened, in plain English

Allergy Laboratories, Inc. is recalling Ephedrine Sulfate Injection, USP, 50 mg/mL single-dose vials because an FDA inspection raised concerns that the product's sterility may have been compromised. The recall covers approximately 1.9 million vials distributed nationwide. Patients and healthcare providers should check their inventory against the specific lot numbers listed in the record. Read more at govinfonow.com/recall/42487-allergy-labs-recalls-ephedrine-sulfate-injection-due-to-sterility-risks.

Source Summary by GovInfoNow · govinfonow.com/recall/42487-allergy-labs-recalls-ephedrine-sulfate-injection-due-to-sterility-risks · Updated October 11, 2026 · FDA enforcement record: FDA #D-1498-2016

Cite this page

“Allergy Labs Recalls Ephedrine Sulfate Injection Due to Sterility Risks.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/42487-allergy-labs-recalls-ephedrine-sulfate-injection-due-to-sterility-risks. Based on FDA recall #D-1498-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1498-2016%22&limit=1).

Why it’s dangerous

The primary hazard is a lack of assurance of sterility. If the vials are not sterile, using them could introduce bacteria or other contaminants into the body, potentially causing serious infections or other adverse health effects.

Who’s affected

Healthcare facilities, pharmacies, and patients who have received or possess Ephedrine Sulfate Injection from Allergy Laboratories, Inc. are affected by this recall.

How to tell if you have this one

Look for Ephedrine Sulfate Injection, USP, 50 mg/mL, packaged in 1 mL fills in 2 mL vials (NDC: 69053-008-01) or cases of 25 x 2 mL vials (NDC: 69053-008-02). Affected lots include 102814, 102914, 103014, 103114, 110314, 110414, 110514, 110614, 110714, 111014, 121014, 121114, 121214, 121514, 011415, 011515, 011615, 012015, 012115, 021315, 021715, 021815, 021915, 022015, 030415, 030515, 030615, 031015, 031715, 042415, 042815, 042915, 043015, 050115, 050515, 052815, 052915, 060315, 060415, 061615, and 061715.

  • Brand
    Allergy Laboratories
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not administer or use any Ephedrine Sulfate Injection vials that match the recalled lot numbers due to potential sterility issues.

  2. Check lot numbers

    Verify if your inventory contains lots 102814 through 061715 with expiration dates from 10/16 to 06/17.

  3. Contact manufacturer

    Reach out to Allergy Laboratories, Inc. or Andersen Pharmaceutical for further instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Aug 10, 201612. FDA classified it Class II: Sep 7, 201623. Published in FDA’s Enforcement Report: Sep 14, 201634. FDA terminated the recall: Mar 13, 2017420162017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC for the recalled product?

The affected National Drug Codes are 69053-008-01 for single vials and 69053-008-02 for cases of 25 vials.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1498-2016 (August 10, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1498-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA